Home›Stock Screener›Fischer Medical Ventures›Quarterly Results

Fischer Medical Ventures Quarterly Results

Latest Quarter Net Profit
₹-12 Cr
QMar 2026
Quarterly Results

Fischer Medical Ventures quarterly results. In Mar 2026, Fischer Medical Ventures (FISCHER) reported revenue ₹98 Cr and net profit ₹-12 Cr — revenue +100.0% YoY. For annual financials, live price and key ratios, visit Fischer Medical Ventures share price chart.

FISCHER Quarterly Results — Revenue, Profit & EPS Highlights

Fischer Medical Ventures latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Review FISCHER P/E comparison to evaluate earnings-based valuation against sector peers.

  • Revenue of ₹98 Cr in Mar 2026 (+18.1% vs Jun 2026, +100.0% vs Mar 2025)
  • Net Profit of ₹-12 Cr in Mar 2026 (-400.0% vs Jun 2026, -1300.0% vs Mar 2025)
  • EBITDA of ₹-3 Cr in Mar 2026 (-123.1% vs Jun 2026)
  • Operating Margin of -4.0% in Mar 2026 (-18.0pp vs Jun 2026)
  • Earnings Per Share of ₹-0.19 in Mar 2026 (-416.7% vs Jun 2026)

Fischer Medical Ventures Quarterly Results — Revenue, EBITDA, Net Profit & EPS

FISCHER quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Mar 2026 Jun 2026 Sept 2025 Mar 2025 Jun 2025 QoQ YoY
Revenue (₹ Cr) 98 83 89 49 31 18.1% 100.0%
Net Profit (₹ Cr) -12 4 14 1 5 - -
EBITDA (₹ Cr) -3 13 19 3 12 - -
EPS (₹) -0.19 0.06 0.22 -0.05 0.08 - -
Operating Margin (%) -4.0% 14.0% 19.0% 5.0% 17.0% - -

FISCHER Share Price Trend — 1-Year Movement Across Quarterly Results

Fischer Medical Ventures 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Check Fischer Medical Ventures networth to track the company's total market size over time.

Profitability Ratios

Profit Margin -12.2%
EBITDA Margin -3.1%
Operating Margin -4.0%
ROE (Annual) -12.5%

Balance Sheet Highlights

Total Assets ₹671 Cr
Total Equity ₹385 Cr
Current Assets ₹418 Cr
Current Liabilities ₹28 Cr

Cash Flow Analysis

Operating Cash Flow ₹-101 Cr
Investing Cash Flow ₹-5 Cr
Financing Cash Flow ₹14 Cr
Net Cash Flow ₹-92 Cr

Current Market Data

Current Price ₹32.80
Exchange NSE
Last Updated Oct 05, 2026

Revenue Trend (₹ Cr)

Mar 2025 49
Sept 2025 89
Jun 2026 83
Mar 2026 98

Net Profit Trend (₹ Cr)

Mar 2025 1
Sept 2025 14
Jun 2026 4
Mar 2026 -12

Operating Margin Trend (%)

Mar 2025 5.0%
Sept 2025 19.0%
Jun 2026 14.0%
Mar 2026 -4.0%

FISCHER vs Chemicals Peers — Quarterly Revenue, Profit & Market Cap

Fischer Medical Ventures latest quarter revenue and net profit vs Chemicals competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Pidilite Industries
Mar 2026 		₹149,017.59 Cr 1487.7 3,648 584 -21.7% - 16.0% 261.5
SRF
Mar 2026 		₹73,697.14 Cr 2460.0 4,557 582 -8.4% - 12.8% 125.3
Linde
Mar 2026 		₹53,281.32 Cr 6041.0 621 77 -11.5% - 12.4% 665.3
Coromandel Internat…
Mar 2026 		₹52,036.94 Cr 1801.4 6,068 115 -26.1% - 1.9% 379.2
Gujarat Fluorochemi…
Mar 2026 		₹50,280.54 Cr 4429.8 1,375 100 -14.1% - 7.3% 446.6
Sector Quarterly Performance Comparison
Chemicals sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data

QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores